Pharmacogenetics for Pain Management in Joint Replacement Patients

Status unconfirmed · Phase 3

Conditions studied: Arthroplasty Complications

In brief

The purpose of this study is to determine the ability to use pharmacogenetic testing in a joint replacement practice to prescribe the most effective pain medicine for a specific patient.

Key facts

Study ID

NCT03772535

Run by

Anderson Orthopaedic Research Institute

People needed

50

Starts

2018-12-03

Expected to finish

2021-12-01

Last updated by the study team

2021-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary total hip or total knee arthroplasty cases

You may not qualify if…

• History of narcotic dependence

Where it is running

• Anderson Orthopaedic Research Institute — Alexandria, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.